86 related articles for article (PubMed ID: 3555766)
21. Blockade of acute grade IV skin and eye graft-versus-host disease by anti-interleukin-2 receptor monoclonal antibody in genoidentical bone marrow transplantation setting.
Ozşahin H; Tuchschmid P; Lauener R; Waldvogel K; Nadal D; Seger RA
Turk J Pediatr; 1998; 40(2):231-5. PubMed ID: 9677728
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous chronic graft-vs-host disease and hepatitis C virus.
Bouloc A; Pawlotsky JM; Choukroun V; Norol F; Vernant JP; Revuz J; Bagot M
Arch Dermatol; 1995 Jul; 131(7):853-5. PubMed ID: 7611812
[No Abstract] [Full Text] [Related]
23. [Skin manifestations of graft-versus-host reaction following bone marrow transplantation].
Itin PH; Lautenschlager S; Orth B; Rufli T; Gratwohl A
Schweiz Med Wochenschr; 1996 Mar; 126(9):339-47. PubMed ID: 8701251
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous chronic graft-versus-host disease localized to the field of total lymphoid irradiation.
Okamoto S; Takahashi S; Inoue T; Tojo A; Tani K; Kikuchi A; Shimizu H; Nishikawa T; Ikeda Y; Asano S
Bone Marrow Transplant; 1996 Jan; 17(1):111-3. PubMed ID: 8673042
[TBL] [Abstract][Full Text] [Related]
25. Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting.
Tutschka PJ
Bone Marrow Transplant; 1993; 12 Suppl 1():34-6. PubMed ID: 8374557
[No Abstract] [Full Text] [Related]
26. Influence of radiation field and fractionation schedule of total lymphoid irradiation (TLI) on the induction of suppressor cells and stable chimerism after bone marrow transplantation in mice.
Waer M; Ang KK; Van der Schueren E; Vandeputte M
J Immunol; 1984 Feb; 132(2):985-90. PubMed ID: 6228603
[TBL] [Abstract][Full Text] [Related]
27. Multiple eccrine poromas in the setting of total body irradiation and immunosuppression.
Mahlberg MJ; McGinnis KS; Draft KS; Fakharzadeh SS
J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S46-9. PubMed ID: 16843124
[TBL] [Abstract][Full Text] [Related]
28. Atypical skin graft-vs.-host disease following bone marrow transplantation in an infant.
Kuskonmaz B; Güçer S; Boztepe G; Cetin M; Uckan D
Pediatr Transplant; 2007 Mar; 11(2):214-6. PubMed ID: 17300504
[TBL] [Abstract][Full Text] [Related]
29. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
30. Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre.
Bruno B; Souillet G; Bertrand Y; Werck-Gallois MC; So Satta A; Bellon G
Bone Marrow Transplant; 2004 Jul; 34(2):143-7. PubMed ID: 15170172
[TBL] [Abstract][Full Text] [Related]
31. [Venous occlusive disease of the liver and autologous bone marrow transplantation. Preventive role for heparin?].
Cahn JY; Flesch M; Plouvier E; Hervé P; Rozenbaum A
Nouv Rev Fr Hematol (1978); 1985; 27(1):27-8. PubMed ID: 3887329
[TBL] [Abstract][Full Text] [Related]
32. Radiation protocols determine acute graft-versus-host disease incidence after allogeneic bone marrow transplantation in murine models.
Schwarte S; Bremer M; Fruehauf J; Sorge Y; Skubich S; Hoffmann MW
Int J Radiat Biol; 2007 Sep; 83(9):625-36. PubMed ID: 17654104
[TBL] [Abstract][Full Text] [Related]
33. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
[TBL] [Abstract][Full Text] [Related]
34. Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation.
Anderson JE; Appelbaum FR; Schoch G; Barnett T; Chauncey TR; Flowers ME; Storb R
Biol Blood Marrow Transplant; 2001; 7(3):163-70. PubMed ID: 11302550
[TBL] [Abstract][Full Text] [Related]
35. Bullous sclerodermalike changes in chronic graft-vs-host disease.
Hymes SR; Farmer ER; Burns WH; Morison WL; Tutschka PJ; Walters LL; Santos GW
Arch Dermatol; 1985 Sep; 121(9):1189-92. PubMed ID: 3899019
[TBL] [Abstract][Full Text] [Related]
36. Late complications after marrow transplantation.
Sullivan KM; Deeg HJ; Sanders JE; Shulman HM; Witherspoon RP; Doney K; Appelbaum FR; Schubert MM; Stewart P; Springmeyer S
Semin Hematol; 1984 Jan; 21(1):53-63. PubMed ID: 6367058
[No Abstract] [Full Text] [Related]
37. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
38. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
39. Toxic absorption of tacrolimus [corrected] in a patient with severe acute graft-versus-host disease.
Neuman DL; Farrar JE; Moresi JM; Vogelsang GB; Higman MA
Bone Marrow Transplant; 2005 Nov; 36(10):919-20. PubMed ID: 16151424
[No Abstract] [Full Text] [Related]
40. [Endocrinal sequela in bone marrow transplantations during childhood and adolescence].
Le Heup B; von Bueltzingloewen A; Bordigoni P; Sommelet D; Pierson M
Ann Pediatr (Paris); 1993 Sep; 40(7):463-8. PubMed ID: 8239398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
